Form 8-K - Current report:
SEC Accession No. 0001558370-19-008672
Filing Date
2019-09-20
Accepted
2019-09-20 16:02:13
Documents
7
Period of Report
2019-09-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 53962
2 EX-10.1 ex-10d1.htm EX-10.1 274658
3 EX-99.1 ex-99d1.htm EX-99.1 13617
4 EX-99.2 ex-99d2.htm EX-99.2 13322
5 GRAPHIC ex-99d1g001.jpg GRAPHIC 1606
6 GRAPHIC ex-99d2g001.jpg GRAPHIC 1606
7 GRAPHIC ex-99d2g002.jpg GRAPHIC 7929
  Complete submission text file 0001558370-19-008672.txt   372696
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 191104718
SIC: 2834 Pharmaceutical Preparations